Clinical Trials on Distrofia Muscular Cinturão Membro, Tipo 2D
Total 0 results
Nothing found
Sponsors and Collaborators
- CTC Bio, Inc.
- Kawin Technology Share-holding Co., Ltd.
- John Granton
- Honda R and D Americas, Inc.
- Marilia Medicine School
- Montreal Neurological Institute and Hospital
- Rex Bionics Plc
- Ionis Pharmaceuticals
- Jeffrey W. Clark, MD
- Wushan County People's Hospital
- Northern California Melanoma Center
- New York State Health Foundation
- European Network For Smoking and Tobacco Prevention
- Mitchell Scheiman
- Health Parametrics Inc.
- MingSight Pharmaceuticals Pty Limited
- Jeffrey Rudolph
- Zahra Rabbani Khah
- Medtronic Atrial Fibrillation Solutions
- The Third Hospital of Changsha
- View Full List
Medical Conditions
- Liver Hemangioma
- H.Pylori Infection
- Advanced Esophageal Cancers
- Primary Generalized Dystonia
- Periferal Arterial Occlusive Disease, PAOD
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Hyperthyroidism, Autoimmune
- LSIL
- Fasting, Diet, Chemotherapy, Toxicity
- HDT-AHCT
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- Waldenstrom's Macroglobulinemia Recurrent
- Locally Advanced NSCLC
- Pancreatic Neoplasms
- ACTH-Secreting Pituitary Adenoma
- Renal Cancer Metastatic
- Brain MRI
- Pregnancy-Related Condition, Unspecified
- Metastatic Spine Lesions
- Ascaris Suum
- View Full List
Drug Interventions
- Levcromakalim
- Postoperative analgesia management
- Bendamustine
- Fludarabine
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Toripalimab plus Anlotinib
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- AZD7798
- Nimotuzumab
- ESK981
- Ombrabulin (AVE8062)
- Levobupivacaine, clonidine
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- CKD-519
- Pentostatin
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- 200 µg doxorubicin-containing MNA
- Hydroxychloroquine
- Rifaximin
- View Full List
CROs by country
- Contract Research Organizations in Burundi
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Georgia
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Kenya
- Contract Research Organizations in Malta
- Contract Research Organizations in Peru
- Contract Research Organizations in Philippines
- Contract Research Organizations in Portugal
- Contract Research Organizations in Serbia
- Contract Research Organizations in Spain
- Contract Research Organizations in Switzerland
- CRO list by country